Table 3.
N (%) | |
---|---|
≥25% increased enhancement | 11 (52) |
Increased T2/FLAIR | 16 (76) |
New lesion | 3 (14) |
Clinical decline | 12 (57) |
Cases meeting single criterion | 7 (33) |
N (%) | |
---|---|
≥25% increased enhancement | 11 (52) |
Increased T2/FLAIR | 16 (76) |
New lesion | 3 (14) |
Clinical decline | 12 (57) |
Cases meeting single criterion | 7 (33) |